J Multimed Inf Syst: Multi-biomarkers-Base Alzheimer’s Disease Classification (original) (raw)

[1].

A. D. International, E. Albanese, M. Guerchet, M. Prince, and M. Prina, “World Alzheimer Report 2014: Dementia and risk reduction: An analysis of protective and modifiable risk factors,” Sep. 2014.

[2].

Alzheimer’s Association, “2018 Alzheimer’s disease facts and figures,” Alzheimer’s Dement., vol. 14, no. 3, pp. 367–429, Mar. 2018.

[3].

G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E. M. Stadlan, “Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease,” Neurology, vol. 34, no. 7, pp. 939–939, 1984.

[4].

B. T. Hyman and J. Q. Trojanowski, “Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease,” J. Neuropathol. Exp. Neurol., vol. 56, no. 10, pp. 1095–1097, 1997.

[5].

I. Garali, M. Adel, S. Bourennane, and E. Guedj, “Histogram-Based Features Selection and Volume of Interest Ranking for Brain PET Image Classification,” IEEE J. Transl. Eng. Health Med., vol. 6, pp. 1–12, 2018.

[6].

D. Lu, K. Popuri, G. W. Ding, R. Balachandar, and M. F. Beg, “Multimodal and Multiscale Deep Neural Networks for the Early Diagnosis of Alzheimer’s Disease using structural MR and FDG-PET images,” Sci. Rep., vol. 8, no. 1, Art. no. 1, 2018.

[7].

Jack CR Jr, Therneau TM, Weigand SD, Wiste HJ, Knopman DS, Vemuri P, Lowe VJ, Mielke MM, Roberts RO, Machulda MM, Graff-Radford J, Jones DT, Schwarz CG, Gunter JL, Senjem ML, Rocca WA, Petersen RC. “Prevalence of Biologically vs Clinically Defined Alzheimer Spectrum Entities Using the National Institute on Aging–Alzheimer’s Association Research Framework,” JAMA Neurol., vol. 76, no. 10, pp. 1174–1183, 2019.

[8].

H. Wei, M. Kong, C. Zhang, L. Guan, M. Ba, and for Alzheimer’s Disease Neuroimaging Initiative*, “The structural MRI markers and cognitive decline in prodromal Alzheimer’s disease: a 2-year longitudinal study,” Quant. Imaging Med. Surg., vol. 8, no. 10, pp. 1004–1019, 2018.

[9].

Liu M, Li F, Yan H, Wang K, Ma Y; Alzheimer’s Disease Neuroimaging Initiative, Shen L, Xu M “A multi-model deep convolutional neural network for automatic hippocampus segmentation and classification in Alzheimer’s disease,” NeuroImage, vol. 208, p. 116459, 2020.

[10].

C. Platero, L. Lin, and M. C. Tobar, “Longitudinal Neuroimaging Hippocampal Markers for Diagnosing Alzheimer’s Disease,” Neuroinformatics, vol. 17, no. 1, pp. 43–61, 2019.

[11].

Zheng, F., Cui, D., Zhang, L., Zhang, S., Zhao, Y., Liu, X., Liu, C., Li, Z., Zhang, D., Shi, L., Liu, Z., Hou, K., Lu, W., Yin, T., & Qiu, J “The Volume of Hippocampal Subfields in Relation to Decline of Memory Recall Across the Adult Lifespan,” Front. Aging Neurosci., vol. 10, p. 320, 2018.

[12].

Kang SH, Park YH, Lee D, Kim JP, Chin J, Ahn Y, Park SB, Kim HJ, Jang H, Jung YH, Kim J, Lee J, Kim JS, Cheon BK, Hahn A, Lee H, Na DL, Kim YJ, Seo SW “The Cortical Neuroanatomy Related to Specific Neuropsychological Deficits in Alzheimer’s Continuum,” Dement. Neurocognitive Disord., vol. 18, no. 3, pp. 77–95, 2019.

[13].

Wu C, Guo S, Hong Y, Xiao B, Wu Y, Zhang Q; Alzheimer’s Disease Neuroimaging Initiative “Discrimination and conversion prediction of mild cognitive impairment using convolutional neural networks,” Quant. Imaging Med. Surg., vol. 8, no. 10, pp. 992–1003, 2018.

[14].

Josephs KA, Dickson DW, Tosakulwong N, Weigand SD, Murray ME, Petrucelli L, Liesinger AM, Senjem ML, Spychalla AJ, Knopman DS, Parisi JE, Petersen RC, Jack CR Jr, Whitwell JL “Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer’s disease: a longitudinal retrospective study,” Lancet Neurol., vol. 16, no. 11, pp. 917–924, 2017.

[15].

Feng F, Wang P, Zhao K, Zhou B, Yao H, Meng Q, Wang L, Zhang Z, Ding Y, Wang L, An N, Zhang X, Liu Y “Radiomic Features of Hippocampal Subregions in Alzheimer’s Disease and Amnestic Mild Cognitive Impairment,” Front. Aging Neurosci., vol. 10, 2018.

[16].

Feng, F., Wang, P., Zhao, K., Zhou, B., Yao, H., Meng, Q., Wang, L., Zhang, Z., Ding, Y., Wang, L., An, N., Zhang, X., & Liu, Y “Radiomic Features of Hippocampal Subregions in Alzheimer’s Disease and Amnestic Mild Cognitive Impairment,” Front. Aging Neurosci., vol. 10, 2018.

[17].

A. Chandra, G. Dervenoulas, M. Politis, and for the Alzheimer’s Disease Neuroimaging Initiative, “Magnetic resonance imaging in Alzheimer’s disease and mild cognitive impairment,” J. Neurol., vol. 266, no. 6, pp. 1293–1302, 2019.

[18].

Ossenkoppele, R., Smith, R., Ohlsson, T., Strandberg, O., Mattsson, N., Insel, P. S., Palmqvist, S., & Hansson, O “Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease,” Neurology, vol. 92, no. 6, pp. e601–e612, 2019.

[19].

Y. Gupta, K. H. Lee, K. Y. Choi, J. J. Lee, B. C. Kim, and G.-R. Kwon, “Alzheimer’s Disease Diagnosis Based on Cortical and Subcortical Features,” Journal of Healthcare Engineering, vol. 2019, Article ID 2492719, pp. 1-13, 2019.

[20].

B. Fischl, “FreeSurfer,” NeuroImage, vol. 62, no. 2, pp. 774–781, 2012.

[21].

D. P. Muni, N. R. Pal, and J. Das, “Genetic programming for simultaneous feature selection and classifier design,” IEEE Trans. Syst. Man Cybern. Part B Cybern., vol. 36, no. 1, pp. 106–117, 2006.

[22].

B. Fischl and A. M. Dale, “Measuring the thickness of the human cerebral cortex from magnetic resonance images,” Proc. Natl. Acad. Sci., vol. 97, no. 20, pp. 11050–11055, Sep. 2000.

[23].

Sørensen, L., Igel, C., Pai, A., Balas, I., Anker, C., Lillholm, M., Nielsen, M., & Alzheimer’s Disease Neuroimaging Initiative and the Australian Imaging Biomarkers and Lifestyle flagship study of ageing “Differential diagnosis of mild cognitive impairment and Alzheimer’s disease using structural MRI cortical thickness, hippocampal shape, hippocampal texture, and volumetry,” NeuroImage Clin., vol. 13, pp. 470–482, 2017.

[24].

Saygin ZM, Kliemann D, Iglesias JE, van der Kouwe AJW, Boyd E, Reuter M, Stevens A, Van Leemput K, McKee A, Frosch MP, Fischl B, Augustinack JC; Alzheimer’s Disease Neuroimaging Initiative “High-resolution magnetic resonance imaging reveals nuclei of the human amygdala: manual segmentation to automatic atlas,” NeuroImage, vol. 155, pp. 370–382, 2017.

[25].

D. Zhang, Y. Wang, L. Zhou, H. Yuan, D. Shen, and Alzheimer’s Disease Neuroimaging Initiative, “Multimodal classification of Alzheimer’s disease and mild cognitive impairment,” NeuroImage, vol. 55, no. 3, pp. 856–867, 2011.

[26].

R. K. Lama, J. Gwak, J.-S. Park, and S.-W. Lee, “Diagnosis of Alzheimer’s Disease Based on Structural MRI Images Using a Regularized Extreme Learning Machine and PCA Features,” Journal of Healthcare Engineering, vol. 2017, Article ID 548580, pp. 1-11, 2017.

[27].

E. Westman, J.-S. Muehlboeck, and A. Simmons, “Combining MRI and CSF measures for classification of Alzheimer’s disease and prediction of mild cognitive impairment conversion,” NeuroImage, vol. 62, no. 1, pp. 229–238, 2012.